tiprankstipranks
Atrium Therapeutics, Inc. (RNA)
NASDAQ:RNA
US Market
RNA
Atrium Therapeutics, Inc.
RESEARCH TOOLSreports
Want to see RNA full AI Analyst Report?

Atrium Therapeutics, Inc. (RNA) Financial Statements

11 Followers

Atrium Therapeutics, Inc. Financial Overview

Atrium Therapeutics, Inc.'s market cap is currently $213.14M. The company's EPS TTM is $; its P/E ratio is -4.58; Atrium Therapeutics, Inc. is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total Revenue$ 18.62M$ 10.90M$ 9.56M$ 9.22M$ 9.33M
Gross Profit$ 18.62M$ 10.90M$ 7.46M$ 7.84M$ -91.86M
Operating Income$ -76.81M$ -378.94M$ -235.60M$ -178.91M$ -118.05M
EBITDA$ -76.50M$ -376.16M$ -233.50M$ -177.53M$ -117.41M
Net Income$ -76.68M$ -322.30M$ -212.22M$ -174.00M$ -118.01M
Balance Sheet
Cash & Short-Term Investments$ 270.00M$ 1.50B$ 595.35M$ 610.73M$ 405.54M
Total Assets$ 278.35M$ 1.56B$ 628.55M$ 638.80M$ 427.58M
Total Debt$ 3.67M$ 6.80M$ 9.85M$ 10.69M$ 11.73M
Net Debt$ -266.33M$ -213.07M$ -175.23M$ -329.71M$ -308.72M
Total Liabilities$ 71.07M$ 138.94M$ 127.79M$ 60.73M$ 46.15M
Stockholders' Equity$ 207.29M$ 1.42B$ 500.76M$ 578.08M$ 381.43M
Cash Flow
Free Cash Flow$ -42.57M$ -307.94M$ -123.29M$ -139.09M$ -98.55M
Operating Cash Flow$ -41.13M$ -300.87M$ -119.06M$ -136.27M$ -94.81M
Investing Cash Flow$ -1.45M$ -854.20M$ -130.07M$ -189.96M$ -82.52M
Financing Cash Flow$ 42.57M$ 1.19B$ 93.86M$ 346.17M$ 176.32M
Currency in USD

Atrium Therapeutics, Inc. Earnings and Revenue History

Income Statement >

Atrium Therapeutics, Inc. Debt to Assets

Balance Sheet >

Atrium Therapeutics, Inc. Cash Flow

Cash Flow >

Atrium Therapeutics, Inc. Forecast EPS vs Actual EPS

Earnings >